Cargando…
Promising Drug Targets and Compounds with Anti-Toxoplasma gondii Activity
Toxoplasmosis is a parasitic disease caused by the globally distributed protozoan parasite Toxoplasma gondii, which infects around one-third of the world population. This disease may result in serious complications for fetuses, newborns, and immunocompromised individuals. Current treatment options a...
Autores principales: | da Silva, Marco, Teixeira, Cátia, Gomes, Paula, Borges, Margarida |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471693/ https://www.ncbi.nlm.nih.gov/pubmed/34576854 http://dx.doi.org/10.3390/microorganisms9091960 |
Ejemplares similares
-
Rhomboid antigens are promising targets in the vaccine development against Toxoplasma gondii
por: Foroutan, Masoud, et al.
Publicado: (2019) -
Drug Resistance in Toxoplasma gondii
por: Montazeri, Mahbobeh, et al.
Publicado: (2018) -
Toxoplasma gondii Chitinase Induces Macrophage Activation
por: Almeida, Fausto, et al.
Publicado: (2015) -
Identification of compounds that suppress Toxoplasma gondii tachyzoites and bradyzoites
por: Murata, Yuho, et al.
Publicado: (2017) -
Toxoplasma gondii
por: Liesenfeld, Oliver
Publicado: (2009)